Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Hyperactivity Disorder (ADHD)

Explore clinical trials studying Attention Deficit Hyperactivity Disorder (ADHD). Study availability and eligibility vary by location and protocol.

77 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Hyperactivity Disorder (ADHD) trial results

Completed

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

NCT02402166

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • AVIDA Newport Beach, California, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
  • Center For Psychiatry and Behavioral Medicine In Las Vegas, Nevada, United States
  • Duke Child and Family Center Durham, North Carolina, United States
View Trial Details
Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT03260205

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex, Inc Dothan, Alabama, United States
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • CMB Clinical Trials Colton, California, United States
  • Sun Valley Research Center Imperial, California, United States
View all 48 locations
View Trial Details
Completed

Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

NCT02604407

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Pharmacology Research Institute Encino, California, United States
  • Pharmacology Research Institute (Pri) Los Alamitos, California, United States
  • Pharmacology Research Institute (Pri) Newport Beach, California, United States
  • Nrc Research Institute Orange, California, United States
View all 45 locations
View Trial Details
Completed

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT02466425

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Nrc Research Institute Orange, California, United States
  • Pcsd Feighner Research San Diego, California, United States
  • Encompass Clinical Research Spring Valley, California, United States
View all 36 locations
View Trial Details
Completed

Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years

NCT03325881

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • PEWMD, PA, ARCSM, PLLC, PRP, Inc. Little Rock, Arkansas, United States
  • Advanced Research Center Anaheim, California, United States
  • Riverside Medical Clinic Riverside, California, United States
View all 41 locations
View Trial Details
Completed

Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD

NCT02578030

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • QPS MRA Miami, Florida, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
  • Houston Clinical Research Houston, Texas, United States
View Trial Details
Completed

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder

NCT02466386

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex, Inc Dothan, Alabama, United States
  • Preferred Research Partners, Inc. Little Rock, Arkansas, United States
  • Sun Valley Research Center Imperial, California, United States
  • Alliance for Wellness d/b/a Alliance for Research Long Beach, California, United States
View all 50 locations
View Trial Details
Completed

Experimental Medicine in ADHD - Cannabinoids

NCT02249299

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +5 more
Locations
  • Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London London, United Kingdom
View Trial Details
Completed

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

NCT01986062

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Florida Clinical Research Center, LLC. Bradenton, Florida, United States
  • Florida Clinical Research Center, LLC Maitland, Florida, United States
  • Miami Research Associates South Miami, Florida, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
View Trial Details

Related conditions